Literature DB >> 6469365

Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration.

P Männistö, M Karhunen, J Mattila, O Koskela, A M Suikkari, P Heinonen, R Tuimala, H Haataja.   

Abstract

Concentrations of metronidazole and tinidazole in serum and gynecological organs were analyzed after a single 500 mg intravenous infusion and after three days of treatment with 400 mg t.i.d. of metronidazole or 500 mg b.i.d. of tinidazole. The studies were performed in 67 patients subjected to hysterectomy and/or oophorectomy because of myomatosis uteri, carcinoma uteri or endometriosis. At the time of organ removal (about 30 min after infusion), metronidazole and tinidazole levels in serum were 14.5 +/- 0.45 mg/l and 12.3 +/- 0.38 mg/l, respectively. Concentrations of both drugs in the uterus and Fallopian tube were about the same as the simultaneous serum levels and concentrations in the ovaries about 55% thereof. At steady-state, the concentrations of tinidazole in serum (23.5 +/- 1.0 mg/l) were remarkably higher than those of metronidazole (13.5 +/- 0.84 mg/l) about three hours after the last oral dose. Drug concentrations in organs of the female reproductive tract were 70 to 100% those of the simultaneous serum levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469365     DOI: 10.1007/bf01640899

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Penetration of the blood brain barrier by metronidazole and tinidazole.

Authors:  A M Jokipii; V V Myllylä; E Hokkanen; L Jokipii
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

2.  Letter: Treatment of a brain abscess due to Bacteroides fragilis with metronidazole.

Authors:  R H George; A J Bint
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

3.  Concentrations of tinidazole in breast milk.

Authors:  P T Männistö; M Karhunen; O Koskela; A M Suikkari; J Mattila; H Haataja
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-09

4.  Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route.

Authors:  J Mattila; P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

5.  Determination of metronidazole and misonidazole and their metabolites in plasma and urine by high-performance liquid chromatography.

Authors:  R A Marques; B Stafford; N Flynn; W Sadée
Journal:  J Chromatogr       Date:  1978-07-01

6.  Concentrations of tinidazole and metronidazole in serum, saliva and alveolar bone.

Authors:  L von Konow; C E Nord
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

7.  Prospective comparative trial of tinidazole and metronidazole as prophylaxis for elective hysterectomy.

Authors:  P S Cocks; R Munro; B Norton; J Nutting; S Shanker; S Cheng
Journal:  Aust N Z J Obstet Gynaecol       Date:  1981-05       Impact factor: 2.100

8.  Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole.

Authors:  H R Ingham; J B Slekon; C M Roxby
Journal:  Br Med J       Date:  1977-10-15

Review 9.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Serum and tissue tinidazole concentrations after intravenous infusion.

Authors:  J Viitanen; O Auvinen; T Tunturi
Journal:  Chemotherapy       Date:  1983       Impact factor: 2.544

View more
  6 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.

Authors:  Reiner Schaumann; Matthias Funke; Eva Janssen; Arne C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

3.  Concentrations of metronidazole and tinidazole in male genital tissues.

Authors:  J Viitanen; H Haataja; P T Männistö
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  Trichomonas vaginalis genital infections: progress and challenges.

Authors:  Laura H Bachmann; Marcia M Hobbs; Arlene C Seña; Jack D Sobel; Jane R Schwebke; John N Krieger; R Scott McClelland; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

Review 5.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

6.  Tinidazole in the treatment of bacterial vaginosis.

Authors:  Nicola R Armstrong; Janet D Wilson
Journal:  Int J Womens Health       Date:  2010-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.